This discrepancy just isn't shared with other dopamine reuptake inhbitors like bupropion, sibutramine, mazindol or tesofensine, which have similar or higher potencies than copyright as dopamine reuptake inhibitors. These findings have evoked a hypothesis that copyright could also purpose as bein